Health Ministry Unveils 'Biotech Accelerator' to Drive Innovation at BIO 2025
Vice Minister of Health for Planning and Development, Abdulaziz Al-Rumaih, announced at the 2025 BIO International Convention in Boston, USA, the launch of the Ministry of Health's new 'Biotech Accelerator' program for biotechnology startups. This initiative, developed in partnership with BioLabs, is designed to stimulate innovation, enhance international collaboration, and empower Saudi biotech companies to elevate healthcare services.
This pioneering program—the first of its kind in the Kingdom and the first BioLabs partnership in the Middle East—supports the objectives of both the Health Sector Transformation Program and the National Biotechnology Strategy, key pillars of Saudi Vision 2030. These initiatives seek to cultivate a thriving society and dynamic economy while positioning Saudi Arabia as a global leader in health innovation.
Running over seven months, the Biotech Accelerator will provide startups with comprehensive training, structured support tracks, and access to cutting-edge research laboratories.
Related Topics :
SFDA Boosts Cooperation with European Institute of Innovation and Technology
Health Minister Inspects Arafat Field Hospital Ahead of Hajj Rituals
Stride into Health: Saudi Launches 'Walk 30' Public Fitness Drive
Makkah Municipality Issues Health Certificate Guidelines for Hajj Season 1446
Short link :
Post Views: 5 Related Stories
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Leaders
9 hours ago
- Leaders
Health Ministry Unveils 'Biotech Accelerator' to Drive Innovation at BIO 2025
Vice Minister of Health for Planning and Development, Abdulaziz Al-Rumaih, announced at the 2025 BIO International Convention in Boston, USA, the launch of the Ministry of Health's new 'Biotech Accelerator' program for biotechnology startups. This initiative, developed in partnership with BioLabs, is designed to stimulate innovation, enhance international collaboration, and empower Saudi biotech companies to elevate healthcare services. This pioneering program—the first of its kind in the Kingdom and the first BioLabs partnership in the Middle East—supports the objectives of both the Health Sector Transformation Program and the National Biotechnology Strategy, key pillars of Saudi Vision 2030. These initiatives seek to cultivate a thriving society and dynamic economy while positioning Saudi Arabia as a global leader in health innovation. Running over seven months, the Biotech Accelerator will provide startups with comprehensive training, structured support tracks, and access to cutting-edge research laboratories. Related Topics : SFDA Boosts Cooperation with European Institute of Innovation and Technology Health Minister Inspects Arafat Field Hospital Ahead of Hajj Rituals Stride into Health: Saudi Launches 'Walk 30' Public Fitness Drive Makkah Municipality Issues Health Certificate Guidelines for Hajj Season 1446 Short link : Post Views: 5 Related Stories
Saudi Gazette
a day ago
- Saudi Gazette
SFDA suspends medical device imports from erring international firm
Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has suspended imports from an international medical device and supplies factory, as part of its ongoing regulatory efforts to verify the safety of products under its supervision circulating in the Saudi market. This import suspension decision followed an SFDA inspection tour that uncovered serious violations, according to a press statement from the authority on Thursday. These issues primarily centered on the factory's quality management system, manufacturing processes, factory work environment and deficiencies that could potentially lead to the contamination of medical devices. Violations related to quality management systems accounted for approximately 10 percent of all recorded violations at medical device factories in 2024. Meanwhile, violations concerning manufacturing processes and the work environment represented a significant 49 percent of the total. According to the statement, this action is one of several measures the SFDA takes when serious violations are found during inspections of facilities exporting medical devices to Saudi Arabia. The import suspension rate reached approximately 30 percent of all factories inspected in 2024. The factory is also registered with several international regulatory authorities, including the US Food and Drug Administration (FDA) and the European Union, and its products are marketed globally. This demonstrates the efficiency and precision of the SFDA's regulatory system, highlighting its strong capabilities in detecting significant violations and implementing necessary measures based on an inspection methodology that aligns with international best practices. The SFDA is committed to rigorous oversight of the imported medical device sector, ensuring that all products in circulation are safe and effective to protect public health and prevent the distribution of potentially harmful devices. It reaffirmed its dedication to implementing all necessary measures to uphold safety and quality standards in this vital sector.
Arab News
2 days ago
- Arab News
Abu Dhabi delegation on US visit seeks healthcare partnerships
A high-level delegation led by the Department of Health — Abu Dhabi, has embarked on a strategic mission to the US from June 14 to 21. The visit reaffirms Abu Dhabi's global leadership in healthcare innovation and reflects its broader vision for healthcare transformation — driven by innovation, investment, and a deep commitment to global collaboration. The delegation is visiting key US cities including Boston, Washington, DC, and Philadelphia, in parallel with Abu Dhabi's participation at BIO International Convention 2025, one of the world's foremost biotechnology events. The visit spotlights the emirate's achievements in AI, digital health, genomics, and clinical research and showcases Abu Dhabi's Health, Endurance, Longevity and Medicine Life Science Cluster, while promoting long-term strategic partnerships with government entities, research institutions, and global innovators. Dr. Noura Khamis Al-Ghaithi, undersecretary of the Department of Health — Abu Dhabi, said: 'This mission reflects our commitment to shaping the future of health through collaboration, innovation, and shared purpose. Our vision is to build a health system that predicts, prevents, acts to restore, and acts to cure, therefore ensuring better outcomes for our communities and beyond. This can only be achieved through meaningful partnerships and a shared ambition to improve lives. We are proud to join our partners in the US to explore new opportunities that advance healthcare, both in the UAE and globally.' The delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the US, aimed at knowledge exchange, investment opportunities, and the signing of new agreements that accelerate the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo.
